AF and asystole are the most common false alerts when using implantable cardiac monitors like its Linq II device, according to the Medtronic. If the accuracy of detection is improved, that should ...

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

The company added that the device will be indicated for both paroxysmal and persistent atrial fibrillation. Citing data from its PULSED AF study, Medtronic (MDT) said that the PulseSelect PFA ...

Hexagon Health and its founder Dr. Shirin Towfigh diled a lawsuit in Delaware today against Medtronic (MDT), alleging Medtronic infringed three of Hexagon’s patents related to hernia mesh treatment ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

2024 (and announced by FDA on October 17), the company issued an “Urgent Medical Device Correction” letter, advising users to do the following: From January 2023 to September 2024, Medtronic ...

Medtronic's miniature leadless pacemaker, the Micra Transcatheter Pacing System (TPS), is expected to secure FDA approval during the company's 2017 fiscal year. That stretches from May 2016 through ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...